Hypogonadotropic Hypogonadism Study

Are you a male ages 18-65 who is overweight and has low testosterone? JBR Clinical Research is conducting a research study to evaluate an investigational medication for individuals with hypogonadotropic hypogonadism to help normalize total testosterone levels. Qualified participants may receive no cost investigational medication or placebo, study-related care, and compensation.

Basic qualifications are:

  • 18-65 years
  • Male
  • Overweight ( BMI > 30 kg/m2 and < 50 kg/m2 )
  • Have hypogonadotropic hypogonadism
  • Not currently on hormonal therapy

If you qualify you may receive:

  • Study related care
  • Investigational medication
  • Compensation for time and travel related to the study

Sign up now to be considered for the study by filling out and submitting your information.


About Hypogonadotropic hypogonadism

Hypogonadotropic hypogonadism (HH) is a form of hypogonadism that is due to a problem with the pituitary gland or hypothalamus.

Male hypogonadism is a condition in which the body doesn’t produce enough testosterone — the hormone that plays a key role in masculine growth and development during puberty — or has an impaired ability to produce sperm or both.

There are several causes of HH:

  • Damage to the pituitary gland or hypothalamus from surgery, injury, tumor, infection, or radiation
  • Genetic defects
  • High doses or long-term use of opioid or steroid (glucocorticoid) medicines
  • Severe stress
  • Nutritional problems (both rapid weight gain or weight loss)
  • Chronic medical diseases, including chronic inflammation or infections
  • Certain medical conditions, such as iron overload